# Czech MedAI â€” Product Features Specification

**Projekt:** Czech MedAI (kÃ³dovÃ© oznaÄenÃ­: Benjamin)  
**Verze:** 1.0  
**Datum:** 12.12.2025  
**Status:** Draft

---

## ğŸ“‹ PÅ™ehled Features

| ID | Feature | Priorita | FÃ¡ze | Status |
|----|---------|----------|------|--------|
| F-001 | QuickConsult | P0 | MVP | Planned |
| F-002 | Multi-Source RAG Pipeline | P0 | MVP | Planned |
| F-003 | Citation System | P0 | MVP | Planned |
| F-004 | Czech Localization | P0 | MVP | Planned |
| F-005 | VZP Integration | P1 | MVP | Planned |
| F-006 | DeepConsult | P2 | v2.0 | Backlog |
| F-007 | Drug Interaction Checker | P2 | v2.0 | Backlog |
| F-008 | EHR Browser Extension | P2 | v2.0 | Backlog |

---

## F-001: QuickConsult â€” RychlÃ© KlinickÃ© Dotazy

### Popis
PrimÃ¡rnÃ­ rozhranÃ­ pro zadÃ¡vÃ¡nÃ­ klinickÃ½ch dotazÅ¯ v pÅ™irozenÃ©m jazyce. SystÃ©m poskytuje struÄnÃ©, pÅ™esnÃ© odpovÄ›di s inline citacemi bÄ›hem nÄ›kolika sekund.

### User Stories

| ID | User Story | Priorita |
|----|------------|----------|
| US-001 | Jako praktickÃ½ lÃ©kaÅ™ chci zadat klinickÃ½ dotaz v ÄeÅ¡tinÄ›, abych rychle zÃ­skal odpovÄ›Ä s citacemi bez nutnosti prohledÃ¡vat vÃ­ce zdrojÅ¯. | P0 |
| US-002 | Jako lÃ©kaÅ™ na urgentnÃ­m pÅ™Ã­jmu chci zÃ­skat odpovÄ›Ä do 5 sekund, abych mohl rychle rozhodovat bÄ›hem akutnÃ­ pÃ©Äe. | P0 |
| US-003 | Jako specialista chci vidÄ›t zdroje odpovÄ›di, abych mohl ovÄ›Å™it informace pÅ™ed aplikacÃ­ v praxi. | P0 |

### FunkÄnÃ­ poÅ¾adavky

| Req ID | PoÅ¾adavek | KritÃ©rium |
|--------|-----------|-----------|
| FR-001.1 | TextovÃ½ input pro dotazy | Max 2000 znakÅ¯, podpora ÄeskÃ½ch znakÅ¯ |
| FR-001.2 | OdpovÄ›Ä ve strukturovanÃ©m formÃ¡tu | 3-5 vÄ›t + inline citace [1][2][3] |
| FR-001.3 | ZobrazenÃ­ zdrojÅ¯ | Seznam referencÃ­ s PMID/DOI/SÃšKL odkazy |
| FR-001.4 | Historie dotazÅ¯ | PoslednÃ­ch 50 dotazÅ¯ s moÅ¾nostÃ­ opakovÃ¡nÃ­ |
| FR-001.5 | Suggested questions | 3 souvisejÃ­cÃ­ follow-up dotazy |

### UI/UX Specifikace

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ” Zadejte klinickÃ½ dotaz...                      [â†’]  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                         â”‚
â”‚  OdpovÄ›Ä:                                               â”‚
â”‚  Lorem ipsum dolor sit amet [1], consectetur            â”‚
â”‚  adipiscing elit [2]. Sed do eiusmod tempor [3].       â”‚
â”‚                                                         â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚  ğŸ“š Zdroje:                                             â”‚
â”‚  [1] Smith et al. (2024) - PMID: 12345678              â”‚
â”‚  [2] SÃšKL - Metformin SPC                              â”‚
â”‚  [3] ÄŒDS Guidelines 2024                               â”‚
â”‚                                                         â”‚
â”‚  ğŸ’¡ SouvisejÃ­cÃ­ dotazy:                                 â”‚
â”‚  â€¢ JakÃ© jsou kontraindikace metforminu?                â”‚
â”‚  â€¢ DÃ¡vkovÃ¡nÃ­ u pacientÅ¯ s renÃ¡lnÃ­ insuficiencÃ­?        â”‚
â”‚  â€¢ Alternativy pÅ™i intoleranci?                        â”‚
â”‚                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### TechnickÃ¡ implementace

| Komponenta | Technologie | Popis |
|------------|-------------|-------|
| Frontend | Next.js + Shadcn/UI | Modal/popup interface |
| API Endpoint | FastAPI | `POST /api/v1/query` |
| LLM | Claude Sonnet 4.5 | GenerovÃ¡nÃ­ odpovÄ›di |
| Orchestrace | LangGraph | Conditional routing |

### Acceptance Criteria

- [ ] OdpovÄ›Ä obsahuje minimÃ¡lnÄ› 2 relevantnÃ­ citace s PMID/DOI
- [ ] Latence odpovÄ›di < 5 sekund pro 95% dotazÅ¯
- [ ] OdpovÄ›Ä je v ÄeÅ¡tinÄ› s korektnÃ­ lÃ©kaÅ™skou terminologiÃ­
- [ ] Citace jsou klikatelnÃ© odkazy na pÅ¯vodnÃ­ zdroj
- [ ] UI je responzivnÃ­ (desktop, tablet, mobile)

### Metriky ÃºspÄ›chu

| Metrika | Target | MÄ›Å™enÃ­ |
|---------|--------|--------|
| Response Time (p95) | < 5s | APM monitoring |
| Citation Accuracy | > 90% | Manual audit |
| User Satisfaction | > 4.0/5 | In-app rating |
| Daily Active Queries | > 50/user | Analytics |

---

## F-002: Multi-Source RAG Pipeline

### Popis
Backend systÃ©m pro inteligentnÃ­ vyhledÃ¡vÃ¡nÃ­ a syntÃ©zu informacÃ­ z vÃ­ce heterogennÃ­ch zdrojÅ¯. VyuÅ¾Ã­vÃ¡ conditional routing pro optimÃ¡lnÃ­ vÃ½bÄ›r retrieval strategie podle typu dotazu.

### Architektura

```
                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                    â”‚   User Query    â”‚
                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                             â”‚
                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”
                    â”‚    Classifier   â”‚
                    â”‚  (Query Type)   â”‚
                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                             â”‚
           â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
           â”‚                 â”‚                 â”‚
    â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”
    â”‚  Drug Info  â”‚   â”‚  Guidelines â”‚   â”‚  Clinical   â”‚
    â”‚   Router    â”‚   â”‚   Router    â”‚   â”‚   Router    â”‚
    â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜
           â”‚                 â”‚                 â”‚
    â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”
    â”‚    SÃšKL     â”‚   â”‚  ÄŒLS JEP    â”‚   â”‚   PubMed    â”‚
    â”‚  Retriever  â”‚   â”‚  Retriever  â”‚   â”‚  Retriever  â”‚
    â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜
           â”‚                 â”‚                 â”‚
           â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                             â”‚
                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”
                    â”‚   Re-ranker     â”‚
                    â”‚ (Cross-encoder) â”‚
                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                             â”‚
                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”
                    â”‚   Generator     â”‚
                    â”‚ (Claude + Cit.) â”‚
                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Query Types & Routing

| Query Type | Trigger Keywords | Primary Source | Secondary |
|------------|------------------|----------------|-----------|
| `drug_info` | lÃ©k, dÃ¡vkovÃ¡nÃ­, kontraindikace, SPC | SÃšKL | PubMed |
| `guidelines` | guidelines, doporuÄenÃ­, postup, lÃ©Äba | ÄŒLS JEP | ESC/ADA |
| `diagnosis` | diagnÃ³za, symptomy, diferenciÃ¡lnÃ­ | PubMed | Guidelines |
| `reimbursement` | Ãºhrada, VZP, pojiÅ¡Å¥ovna, cena | VZP/SÃšKL | â€” |
| `interaction` | interakce, kombinace, kontraindikace | SÃšKL | DrugBank |
| `general` | (default) | PubMed | All |

### FunkÄnÃ­ poÅ¾adavky

| Req ID | PoÅ¾adavek | KritÃ©rium |
|--------|-----------|-----------|
| FR-002.1 | Query classification | Accuracy > 95% na test setu |
| FR-002.2 | Multi-source retrieval | ParalelnÃ­ dotazy, timeout 3s |
| FR-002.3 | Semantic search | Top-10 dokumentÅ¯, similarity > 0.7 |
| FR-002.4 | Re-ranking | Cross-encoder, top-3 relevance > 0.8 |
| FR-002.5 | Source attribution | 100% odpovÄ›dÃ­ s traceable sources |

### Retriever Specifications

#### SÃšKL Retriever
```yaml
type: vector_store
database: supabase_pgvector
embedding_model: text-embedding-3-small
chunk_size: 512
overlap: 50
index: ivfflat
sources:
  - DLP (databÃ¡ze lÃ©ÄivÃ½ch pÅ™Ã­pravkÅ¯)
  - SPC (souhrny ÃºdajÅ¯ o pÅ™Ã­pravku)
  - PIL (pÅ™Ã­balovÃ© informace)
update_frequency: weekly
```

#### PubMed Retriever
```yaml
type: api_hybrid
api: ncbi_e-utilities
search: semantic + keyword
max_results: 20
filters:
  - publication_date: last_10_years
  - language: [eng, cze]
  - article_type: [clinical_trial, meta_analysis, review]
cache_ttl: 24h
```

#### Guidelines Retriever
```yaml
type: vector_store
database: supabase_pgvector
sources:
  - cls_jep: ÄŒeskÃ© odbornÃ© spoleÄnosti
  - esc: European Society of Cardiology
  - ada: American Diabetes Association
chunk_size: 1024
overlap: 100
update_frequency: quarterly
```

### Acceptance Criteria

- [ ] Query classifier dosahuje > 95% accuracy
- [ ] Semantic search vracÃ­ top-10 relevantnÃ­ch dokumentÅ¯
- [ ] Re-ranking zajiÅ¡Å¥uje relevanci > 0.8 pro top-3 vÃ½sledky
- [ ] ParalelnÃ­ retrieval z 3+ zdrojÅ¯ < 3s
- [ ] Fallback strategie pÅ™i vÃ½padku zdroje

---

## F-003: Citation System

### Popis
AutomatickÃ© generovÃ¡nÃ­ inline citacÃ­ s referencemi. ZajiÅ¡Å¥uje transparentnost a ovÄ›Å™itelnost kaÅ¾dÃ© odpovÄ›di.

### FormÃ¡t citacÃ­

#### Inline citace
```
Text odpovÄ›di s tvrzenÃ­m [1] a dalÅ¡Ã­m faktem [2][3].
```

#### Reference list
```markdown
## Zdroje

[1] **Smith J, et al.** (2024) Title of the study. 
    Journal Name. PMID: 12345678
    ğŸ”— https://pubmed.ncbi.nlm.nih.gov/12345678

[2] **SÃšKL** - Metformin 500mg SPC
    Datum aktualizace: 2024-11-15
    ğŸ”— https://www.sukl.cz/...

[3] **ÄŒDS** - DoporuÄenÃ© postupy pro lÃ©Äbu DM2 (2024)
    ğŸ”— https://www.diab.cz/...
```

### Typy citacÃ­

| Typ | Prefix | PÅ™Ã­klad |
|-----|--------|---------|
| PubMed | PMID | PMID: 12345678 |
| DOI | DOI | DOI: 10.1000/xyz123 |
| SÃšKL | SÃšKL | SÃšKL-12345 |
| Guidelines | ÄŒLS/ESC/ADA | ÄŒDS-2024-DM2 |
| VZP | VZP | VZP-Â§15 |

### FunkÄnÃ­ poÅ¾adavky

| Req ID | PoÅ¾adavek | KritÃ©rium |
|--------|-----------|-----------|
| FR-003.1 | Inline citation generation | KaÅ¾dÃ© faktickÃ© tvrzenÃ­ mÃ¡ citaci |
| FR-003.2 | Reference formatting | KonzistentnÃ­ formÃ¡t dle typu zdroje |
| FR-003.3 | Clickable links | VÅ¡echny citace jsou klikatelnÃ© |
| FR-003.4 | Source verification | Link checker validuje dostupnost |
| FR-003.5 | Citation metadata | Autor, rok, titul, identifikÃ¡tor |

### Acceptance Criteria

- [ ] 100% odpovÄ›dÃ­ obsahuje alespoÅˆ jednu citaci
- [ ] Citace jsou klikatelnÃ© odkazy na pÅ¯vodnÃ­ zdroj
- [ ] FormÃ¡t citace je konzistentnÃ­ a profesionÃ¡lnÃ­
- [ ] Broken links jsou detekovÃ¡ny a nahrazeny alternativou

---

## F-004: Czech Localization

### Popis
PlnÃ¡ podpora ÄeskÃ©ho jazyka vÄetnÄ› lÃ©kaÅ™skÃ© terminologie, automatickÃ© pÅ™eklady anglickÃ½ch zdrojÅ¯ s uvedenÃ­m originÃ¡lu.

### Komponenty lokalizace

| Komponenta | Popis |
|------------|-------|
| UI Strings | KompletnÃ­ ÄeskÃ© rozhranÃ­ |
| Medical Terminology | ÄŒeskÃ¡ lÃ©kaÅ™skÃ¡ terminologie (MeSH CZ) |
| Abbreviations | AutomatickÃ© vysvÄ›tlenÃ­ zkratek |
| Translation Layer | PÅ™eklad anglickÃ½ch abstracts |
| Date/Number Format | ÄŒeskÃ© formÃ¡tovÃ¡nÃ­ |

### TerminologickÃ½ slovnÃ­k

```yaml
terminology_sources:
  - mesh_czech: MeSH ÄeskÃ© pÅ™eklady
  - sukl_terminology: SÃšKL terminologie
  - cls_glossary: ÄŒLS JEP slovnÃ­k
  
abbreviation_handling:
  first_use: "plnÃ½ nÃ¡zev (zkratka)"
  subsequent: "zkratka"
  
examples:
  - "diabetes mellitus 2. typu (DM2)" â†’ "DM2"
  - "glomerulÃ¡rnÃ­ filtrace (GFR)" â†’ "GFR"
  - "akutnÃ­ infarkt myokardu (AIM)" â†’ "AIM"
```

### Translation Layer

```yaml
translation_config:
  source_detection: automatic
  target_language: cs
  preserve_original: true
  format: |
    [PÅ™eklad]: ÄŒeskÃ© znÄ›nÃ­
    [OriginÃ¡l]: English original
  
  excluded_from_translation:
    - proper_nouns
    - drug_names (use Czech registration)
    - study_names
    - acronyms
```

### Acceptance Criteria

- [ ] UI kompletnÄ› v ÄeÅ¡tinÄ› bez anglickÃ½ch fragmentÅ¯
- [ ] LÃ©kaÅ™skÃ¡ terminologie odpovÃ­dÃ¡ ÄeskÃ½m standardÅ¯m
- [ ] Zkratky jsou vysvÄ›tleny pÅ™i prvnÃ­m pouÅ¾itÃ­
- [ ] PÅ™eloÅ¾enÃ© texty zachovÃ¡vajÃ­ odkaz na originÃ¡l
- [ ] Podpora ÄeskÃ½ch znakÅ¯ (hÃ¡Äky, ÄÃ¡rky)

---

## F-005: VZP Integration

### Popis
ZobrazenÃ­ informacÃ­ o ÃºhradÄ› lÃ©kÅ¯ a vÃ½konÅ¯ zdravotnÃ­mi pojiÅ¡Å¥ovnami. PodmÃ­nky Ãºhrady, omezenÃ­, preskripÄnÃ­ limity.

### Data Sources

| Zdroj | Typ dat | Aktualizace |
|-------|---------|-------------|
| SÃšKL LEK-13 | Ceny, Ãºhrady, vÃ½deje | MÄ›sÃ­ÄnÄ› |
| VZP ÄÃ­selnÃ­ky | VÃ½kony, body, omezenÃ­ | KvartÃ¡lnÄ› |
| SÃšKL pÅ™ehledy | PreskripÄnÃ­ omezenÃ­ | TÃ½dnÄ› |

### ZobrazovanÃ© informace

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’Š Metformin 500mg (SIOFOR)                           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                         â”‚
â”‚  ğŸ’° Ãšhrada VZP:                                         â”‚
â”‚  â”œâ”€ ZÃ¡kladnÃ­ Ãºhrada: 45,50 KÄ / 60 tbl                 â”‚
â”‚  â”œâ”€ Doplatek pacienta: 12,00 KÄ                        â”‚
â”‚  â””â”€ MaximÃ¡lnÃ­ cena: 57,50 KÄ                           â”‚
â”‚                                                         â”‚
â”‚  ğŸ“‹ PodmÃ­nky Ãºhrady:                                    â”‚
â”‚  â”œâ”€ IndikaÄnÃ­ omezenÃ­: DM2 (E11)                       â”‚
â”‚  â”œâ”€ PreskripÄnÃ­ omezenÃ­: Å½Ã¡dnÃ©                         â”‚
â”‚  â””â”€ MnoÅ¾stevnÃ­ limit: Bez omezenÃ­                      â”‚
â”‚                                                         â”‚
â”‚  âš ï¸ PoznÃ¡mky:                                           â”‚
â”‚  â€¢ Ãšhrada podmÃ­nÄ›na diagnÃ³zou E11                      â”‚
â”‚  â€¢ Kombinace s jinÃ½mi PAD bez omezenÃ­                  â”‚
â”‚                                                         â”‚
â”‚  ğŸ“… Platnost dat: 01.12.2025                           â”‚
â”‚                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### FunkÄnÃ­ poÅ¾adavky

| Req ID | PoÅ¾adavek | KritÃ©rium |
|--------|-----------|-----------|
| FR-005.1 | Drug price lookup | Cena + Ãºhrada pro 90%+ bÄ›Å¾nÃ½ch lÃ©kÅ¯ |
| FR-005.2 | Reimbursement conditions | IndikaÄnÃ­ omezenÃ­, preskripce |
| FR-005.3 | Patient copay calculation | Doplatek = cena - Ãºhrada |
| FR-005.4 | Alternative suggestions | Generika, biosimilars |
| FR-005.5 | Data freshness indicator | Datum poslednÃ­ aktualizace |

### Acceptance Criteria

- [ ] ZobrazenÃ­ ÃºhradovÃ½ch podmÃ­nek pro 90%+ bÄ›Å¾nÃ½ch lÃ©kÅ¯
- [ ] Data aktualizovÃ¡na minimÃ¡lnÄ› mÄ›sÃ­ÄnÄ›
- [ ] JasnÃ© zobrazenÃ­ doplatku pacienta
- [ ] UpozornÄ›nÃ­ na preskripÄnÃ­ omezenÃ­

---

## F-006: DeepConsult â€” HloubkovÃ¡ AnalÃ½za (v2.0)

### Popis
RozÅ¡Ã­Å™enÃ½ reÅ¾im pro komplexnÃ­ dotazy vyÅ¾adujÃ­cÃ­ hlubÅ¡Ã­ analÃ½zu, porovnÃ¡nÃ­ vÃ­ce zdrojÅ¯, syntÃ©zu guidelines.

### KlÃ­ÄovÃ© funkce

| Funkce | Popis |
|--------|-------|
| Multi-source comparison | PorovnÃ¡nÃ­ CZ vs. mezinÃ¡rodnÃ­ guidelines |
| Evidence grading | GRADE hodnocenÃ­ sÃ­ly dÅ¯kazÅ¯ |
| Conflict resolution | Identifikace rozporÅ¯ mezi zdroji |
| Extended reasoning | Chain-of-thought vysvÄ›tlenÃ­ |
| Export | PDF report pro dokumentaci |

### UI Concept

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”¬ DeepConsult                                         â”‚
â”‚  â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚                                                         â”‚
â”‚  ğŸ“ Dotaz:                                              â”‚
â”‚  "OptimÃ¡lnÃ­ lÃ©Äba DM2 u pacienta s CKD G3b"            â”‚
â”‚                                                         â”‚
â”‚  â³ Analyzuji... (15-30s)                               â”‚
â”‚  â”œâ”€ [âœ“] PubMed meta-analyses                           â”‚
â”‚  â”œâ”€ [âœ“] ÄŒDS Guidelines 2024                            â”‚
â”‚  â”œâ”€ [âœ“] ADA Standards 2024                             â”‚
â”‚  â”œâ”€ [~] KDIGO Guidelines                               â”‚
â”‚  â””â”€ [ ] SÃšKL contraindications                         â”‚
â”‚                                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                         â”‚
â”‚  ğŸ“Š SrovnÃ¡nÃ­ Guidelines:                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚  â”‚ Aspekt   â”‚ ÄŒDS 2024   â”‚ ADA 2024   â”‚                â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤                â”‚
â”‚  â”‚ 1. volba â”‚ Metformin* â”‚ SGLT2i     â”‚                â”‚
â”‚  â”‚ eGFR <45 â”‚ Redukce    â”‚ Stop       â”‚                â”‚
â”‚  â”‚ ...      â”‚ ...        â”‚ ...        â”‚                â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚  * s Ãºpravou dÃ¡vky                                      â”‚
â”‚                                                         â”‚
â”‚  ğŸ“ˆ SÃ­la dÅ¯kazÅ¯: â­â­â­â­ (GRADE A)                       â”‚
â”‚                                                         â”‚
â”‚  [ğŸ“„ Export PDF]  [ğŸ“‹ KopÃ­rovat]  [ğŸ”„ RozÅ¡Ã­Å™it]        â”‚
â”‚                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Acceptance Criteria (v2.0)

- [ ] Response time < 30s
- [ ] MinimÃ¡lnÄ› 3 zdroje v analÃ½ze
- [ ] GRADE evidence rating
- [ ] ExportovatelnÃ½ PDF report

---

## F-007: Drug Interaction Checker (v2.0)

### Popis
Kontrola lÃ©kovÃ½ch interakcÃ­ z SÃšKL databÃ¡ze a mezinÃ¡rodnÃ­ch zdrojÅ¯ (DrugBank).

### Funkce

| Funkce | Popis |
|--------|-------|
| Multi-drug input | ZadÃ¡nÃ­ seznamu lÃ©kÅ¯ pacienta |
| Interaction matrix | Vizualizace vÅ¡ech interakcÃ­ |
| Severity grading | ZÃ¡vaÅ¾nost: mÃ­rnÃ¡/stÅ™ednÃ­/zÃ¡vaÅ¾nÃ¡/kontraindikace |
| Clinical relevance | KlinickÃ½ dopad a doporuÄenÃ­ |
| Alternative suggestions | NÃ¡vrh alternativ bez interakce |

### Severity Levels

| Level | Barva | Akce |
|-------|-------|------|
| ğŸŸ¢ MÃ­rnÃ¡ | ZelenÃ¡ | Monitorovat |
| ğŸŸ¡ StÅ™ednÃ­ | Å½lutÃ¡ | ZvÃ¡Å¾it alternativu |
| ğŸŸ  ZÃ¡vaÅ¾nÃ¡ | OranÅ¾ovÃ¡ | Upravit dÃ¡vkovÃ¡nÃ­ |
| ğŸ”´ Kontraindikace | ÄŒervenÃ¡ | Nekombinovat |

---

## F-008: EHR Browser Extension (v2.0)

### Popis
Browser extension pro integraci Czech MedAI pÅ™Ã­mo do existujÃ­cÃ­ch EHR/NIS systÃ©mÅ¯.

### PodporovanÃ© systÃ©my

| EHR SystÃ©m | VÃ½robce | Integrace |
|------------|---------|-----------|
| IKIS | ICZ | Overlay |
| Medicus | CGM | Overlay |
| STAPRO | STAPRO | Overlay |
| Galen | Galen | Overlay |

### Funkce

| Funkce | Popis |
|--------|-------|
| Context extraction | AutomatickÃ© ÄtenÃ­ diagnÃ³zy/lÃ©kÅ¯ z EHR |
| Floating widget | PlovoucÃ­ okno pro dotazy |
| Quick insert | VloÅ¾enÃ­ odpovÄ›di do EHR poznÃ¡mky |
| Audit trail | LogovÃ¡nÃ­ pouÅ¾itÃ­ pro compliance |

### UI Concept

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ EHR SYSTÃ‰M (IKIS)                       â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚
â”‚ Pacient: Jan NovÃ¡k (*1955)              â”‚
â”‚ Dg: E11.9, I10, E78.0                   â”‚
â”‚ Medikace: Metformin, Lisinopril, Ator.. â”‚
â”‚                                         â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”‚
â”‚    â”‚ ğŸ¤– Czech MedAI          â”‚          â”‚
â”‚    â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚          â”‚
â”‚    â”‚ Kontext: DM2, HTN, HLP  â”‚          â”‚
â”‚    â”‚                         â”‚          â”‚
â”‚    â”‚ ğŸ” [Zadejte dotaz...]   â”‚          â”‚
â”‚    â”‚                         â”‚          â”‚
â”‚    â”‚ ğŸ’¡ DoporuÄenÃ©:          â”‚          â”‚
â”‚    â”‚ â€¢ CÃ­lovÃ¡ HbA1c?         â”‚          â”‚
â”‚    â”‚ â€¢ Kombinace lÃ©Äby?      â”‚          â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ“Š Feature Prioritization Matrix

| Feature | Impact | Effort | Priority | Phase |
|---------|--------|--------|----------|-------|
| QuickConsult | ğŸ”´ High | ğŸŸ¡ Medium | P0 | MVP |
| RAG Pipeline | ğŸ”´ High | ğŸ”´ High | P0 | MVP |
| Citation System | ğŸ”´ High | ğŸŸ¢ Low | P0 | MVP |
| Czech Localization | ğŸ”´ High | ğŸŸ¡ Medium | P0 | MVP |
| VZP Integration | ğŸŸ¡ Medium | ğŸŸ¡ Medium | P1 | MVP |
| DeepConsult | ğŸŸ¡ Medium | ğŸ”´ High | P2 | v2.0 |
| Drug Interactions | ğŸŸ¡ Medium | ğŸŸ¡ Medium | P2 | v2.0 |
| EHR Extension | ğŸŸ¢ Low | ğŸ”´ High | P2 | v2.0 |

---

## ğŸ¯ MVP Definition

### Included (Must Have)
- âœ… F-001: QuickConsult
- âœ… F-002: Multi-Source RAG Pipeline
- âœ… F-003: Citation System
- âœ… F-004: Czech Localization
- âœ… F-005: VZP Integration (basic)

### Excluded (v2.0+)
- âŒ F-006: DeepConsult
- âŒ F-007: Drug Interaction Checker
- âŒ F-008: EHR Browser Extension

### MVP Success Criteria
- [ ] 100 MAU po 3 mÄ›sÃ­cÃ­ch
- [ ] NPS > 40
- [ ] Response time < 5s (p95)
- [ ] Citation accuracy > 90%

---

*Dokument vytvoÅ™en: 12.12.2025*
